Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection

An high performance liquid chromatography (HPLC)–UV method for the simultaneous determination of the free forms of mycophenolic acid (MPA) and its phenol glucuronide (MPAG) in human serum samples was developed for the first time. tographic separation was performed on octadecylsilane based stationary phase in combination with a mobile phase of methanol/buffered tetrabutylammonium (TBA) salt mixture. pretreatment consisted of an ultrafiltration step followed by clean-up/enrichment on a C18 solid-phase extraction (SPE) cartridge. Average recoveries of (99.7 ± 0.2)% and (64.1 ± 6.9)% for free MPA and MPAG, respectively, were estimated in the concentration range from 0.5 to 10 μg/ml. The within-day and between-days coefficients of variation were 0.4 and 0.8% for free MPA (0.1 μg/ml spiking level) and 0.8 and 1.6% for free MPAG (5 μg/ml spiking level), respectively. The linear ranges for free MPA and MPAG were 0.06–1 and 0.2–10 μg/ml, respectively. Detection limits of 4 and 17 ng/ml for free MPA and MPAG were estimated in spiked serum. me HPLC method was also capable of a simultaneous determination of the total concentration of MPA and MPAG when coupled to a proper sample pretreatment step. The potential of the method is demonstrated by excretion kinetics measurement in serum of patients receiving MMF therapy.